Authors


Aldo P. Maggioni, MD

Latest:

The prognostic role of metabolic syndrome after myocardial infarction

We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.



Pamela Nerheim

Latest:

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

The effects of recurrent tachycardia after resolution of cardiomyopathy have not been thoroughly assessed. We evaluated and followed 24 patients with tachycardia-induced cardiomyopathy for more than 12 years. Our observations showed that patients with tachycardia-induced cardiomyopathy may be at long-term risk for sudden death. Surreptitious cardiomyopathy due to occult ultrastructural changes may persist. It has yet to be determined whether rapid and aggressive rate control would prevent structural damage to risk of sudden cardiac death.


John S. Rumsfeld, MD, PhD2-4

Latest:

Exercise capacity on treadmill predicts future cardiac events

Reduced exercise capacity is associated with an increased risk of myocardial infarction, unstable angina, and coronary revascularization in patients referred for exercise treadmill testing for clinical indications.




Nina Ghosh, MD1

Latest:

How do cardiac and noncardiac conditions affect survival after ICD implantation?

The benefits of implantable cardioverter-defibrillators (ICDs) have been shown in randomized clinical trials. The factors that affect the risk–benefit ratio in a community setting, however, have not been evaluated.


Sponsored by Pfizer

Latest:

Bridging Gaps, Expanding Outreach: Identifying the Unmet Needs of Women Living with Metastatic Breast Cancer

The purpose of this Priority Report is to raise awareness of metastatic breast cancer.


Benjamin C. Sullivan, CFP

Latest:

Everyone Hates Prenups, Until...

A prenuptial agreement is the hard, clear-eyed antithesis of the rosy optimism newlyweds bring to the altar.


Brandon May

Latest:

Daclatasvir-Sofosbuvir-Ribavirin Combination Similar to VEL/SOF Plus RBV for Hepatitis C Genotypes

Treatment regimens comprised of DCV+SOF±RBV and VEL/SOF+RBV offer similar cure rates among HCV patients with genotypes 2 and 3.







2Sunnybrook Health Sciences Centre

Latest:

How do cardiac and noncardiac conditions affect survival after ICD implantation?

The benefits of implantable cardioverter-defibrillators (ICDs) have been shown in randomized clinical trials. The factors that affect the risk–benefit ratio in a community setting, however, have not been evaluated.


Chitra Sadasiwan, MD

Latest:

Colonic Carcinoids: Recognizing the Signs, Sites, and Treatment Options

Carcinoids are rare neuroendocrine tumors. More than 75% of patients present with cutaneous flushing and diarrhea. About 8% of these tumors occur in the colon. Carcinoid tumors are recognized by their histologic patterns seen on Masson's stain, Grimelius'stain, and immunohistochemistry and in situ hybridization. Evidence of the elevation of 2 biochemical markers?plasma chromogranin A and urinary 5-hydroxyindoleacetic acid?is usually sufficient for diagnosis. This article discusses the diagnosis, localization, and current and investigational treatment options for carcinoids of the colon.


Susan S. Night, JD, LLM, PhD(c), Intercultural Cancer Council

Latest:

Clinical Trial Disparities: A Case for Diversity

The challenge of eliminating disparities in clinical trials is being addressed by the Eliminating Disparities in Clinical Trials (EDICT) project, which recognizes that broadening diversity in clinical trials will result in improved effectiveness and safety of future medicines, improved trial quality, and reduced discrepancies in health equity.




Dennis Bittner, PhD

Latest:

Using Telepsychiatry With High-Risk Patients in Rural New York State

Telepsychiatry shown to be viable alternative in rural areas with limited access.





Michael W. Stevenson, RPh, PhD

Latest:

Developing New Tools to Assess the Impact of Familial Chylomicronemia Syndrome

The development of new tools to quantify the many ways that rare diseases like FCS can affect patients is imperative.


Afroze Abbas, MRCP

Latest:

Mortality of patients with diabetes mellitus and acute myocardial infarction

We evaluated trends in the treatment and mortality of patients with and without diabetes mellitus and acute myocardial infarction over the last decade. Despite improvements in the provision of evidence-based care, patients with diabetes did not derive improvements in long-term survival.



Nithima Chaowalit, MD

Latest:

Stress echocardiography in diabetes mellitus

We assessed how well dobutamine stress echocardiography predicted morbidity and mortality in 2349 patients with diabetes mellitus over a follow-up period of 13.2 years. Results showed that age, failure to achieve the target heart rate, and the percentage of ischemic segments were independent predictors of both mortality and cardiovascular morbidity. Using clinical and stress echocardiographic parameters, a simple model for risk stratification was developed.


Aplastic Anemia

Latest:

Pediatric MDS Update with Dr. Inga Hofmann Zhang

Dr. Inga Hofman Zhang from the University of Wisconsin School of Medicine provides an update on treating MDS in children.


© 2023 MJH Life Sciences

All rights reserved.